Alpha Blockers
Key Points
- Alpha-1 blockers inhibit norepinephrine at alpha-1 receptors → vasodilation (antihypertensive) and smooth muscle relaxation in bladder neck/prostate (BPH).
- First-dose effect: Marked orthostatic hypotension with initial dose — administer first dose at bedtime to minimize fall risk.
- Concurrent use with PDE5 inhibitors (sildenafil, tadalafil) causes severe hypotension — Black Box Warning.
- Tamsulosin (Flomax) is prostate-selective (uroselective); doxazosin has both antihypertensive and BPH indications.
- Tamsulosin may also be used to facilitate ureteral stone passage in selected clients with urolithiasis.
Pathophysiology
Alpha-1 adrenergic receptors are located on vascular smooth muscle and the prostate/bladder neck. Norepinephrine binding to alpha-1 receptors causes vasoconstriction and urethral smooth muscle contraction (contributing to BPH obstructive symptoms).
Alpha-1 blockers competitively antagonize these receptors, producing:
- Antihypertensive effect: Vasodilation → decreased peripheral vascular resistance → lowered blood pressure
- BPH effect: Smooth muscle relaxation in prostate/bladder neck → improved urinary flow
Classification
| Subtype | Examples | Primary Use |
|---|---|---|
| Non-uroselective | Doxazosin (Cardura), terazosin (Hytrin), prazosin (Minipress) | Hypertension and/or BPH |
| Uroselective | Tamsulosin (Flomax), alfuzosin (Uroxatral), silodosin (Rapaflo) | BPH only; minimal BP effect |
Nursing Assessment
NCLEX Focus
The first-dose effect of alpha blockers causes significant orthostatic hypotension. Instruct patients to take the first dose at bedtime and to rise slowly from lying to sitting to standing after starting therapy.
- Assess baseline blood pressure (standing and supine) and heart rate.
- Assess for concurrent PDE5 inhibitor use (erectile dysfunction drugs) — severe hypotension risk.
- Assess for prostate cancer — alpha blockers treat BPH symptoms, but cancer must be ruled out first (similar presentation).
- Assess PSA (prostate-specific antigen) baseline — alpha blockers do not affect PSA levels (unlike 5-alpha-reductase inhibitors which can reduce PSA ~50%).
- Assess fall risk, especially in older adults receiving first dose.
Nursing Interventions
- Administer first dose at bedtime to minimize first-dose hypotensive effect.
- Instruct patients to rise slowly from lying/sitting to minimize orthostatic hypotension; sit at bedside before standing.
- Tamsulosin: take with the same meal each day (breakfast or dinner); avoid high-fat meals with some formulations.
- When used for medical-expulsive therapy in urolithiasis, reinforce hydration and report persistent severe pain, fever, or low urine output.
- Caution patient not to take with grapefruit juice — CYP3A4 interaction.
- Monitor for retrograde ejaculation (semen enters bladder rather than being expelled) — harmless but should be disclosed to patients.
PDE5 Inhibitor Interaction — Black Box Warning
Concurrent alpha blocker + PDE5 inhibitor (sildenafil, tadalafil, vardenafil) → additive vasodilation → severe symptomatic hypotension. Allow ≥4 hours between doses; avoid nitrates with PDE5 inhibitors.
First-Dose Effect
Prazosin, doxazosin, and terazosin cause significant orthostatic hypotension with the first dose. Start at lowest dose; administer at bedtime; reassess blood pressure after first dose.
Pharmacology
| Drug | Dose | Use | Key Notes |
|---|---|---|---|
| Tamsulosin (Flomax) | 0.4–0.8 mg orally once daily | BPH; selected ureteral stone passage support | Uroselective; take with meal; monitor orthostatic symptoms; intraoperative floppy iris syndrome (cataract surgery) |
| Doxazosin (Cardura) | 1–8 mg orally once daily | Hypertension and BPH | Start at 1 mg; titrate at 1-2 week intervals |
| Terazosin (Hytrin) | 1–10 mg orally once daily | Hypertension and BPH | Start at 1 mg at bedtime |
| Prazosin (Minipress) | 1–20 mg/day in divided doses | Hypertension; PTSD nightmares | First-dose effect prominent |
Clinical Judgment Application
Clinical Scenario
A 68-year-old man with BPH starts tamsulosin 0.4 mg once daily. He calls the clinic reporting dizziness when standing up from his recliner.
- Recognize Cues: Orthostatic hypotension from alpha-1 blockade causing peripheral vasodilation.
- Analyze Cues: Common alpha blocker side effect; medication-induced orthostasis.
- Prioritize Hypotheses: Fall risk from orthostatic dizziness.
- Generate Solutions: Reinforce slow positional changes; assess blood pressure lying and standing.
- Take Action: Educate on rising slowly; assess home fall risk; dosing timing review.
- Evaluate Outcomes: Dizziness resolves with slow positional changes; no falls.
Related Concepts
- antihypertensives - Alpha blockers as one class within antihypertensive pharmacology.
- benign-prostatic-hyperplasia - Primary urological indication for uroselective alpha blockers.
- fall-prevention - Alpha blocker orthostatic hypotension is a modifiable fall risk.
- erectile-dysfunction - PDE5 inhibitor interaction risk.
Self-Check
- What is the “first-dose effect” of alpha blockers, and how can nursing care minimize this risk?
- Why is concurrent use of alpha blockers and PDE5 inhibitors dangerous?
- How do uroselective alpha blockers (tamsulosin) differ from non-selective ones (doxazosin)?